Viewing Study NCT03764293


Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2025-12-25 @ 11:19 PM
Study NCT ID: NCT03764293
Status: COMPLETED
Last Update Posted: 2024-02-06
First Post: 2018-11-28
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-06-10
Start Date Type: ACTUAL
Primary Completion Date: 2022-02-08
Primary Completion Date Type: ACTUAL
Completion Date: 2023-06-14
Completion Date Type: ACTUAL
First Submit Date: 2018-11-28
First Submit QC Date: None
Study First Post Date: 2018-12-05
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-11-10
Results First Submit QC Date: None
Results First Post Date: 2024-02-06
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-05
Last Update Post Date: 2024-02-06
Last Update Post Date Type: ACTUAL